DAB2IP and chronic obstructive pulmonary disease: Conversely, the expression of the onco-suppressor DAB2IP significantly decreased in the epithelium of COPD (smokers and ex-smokers) patients, and of Smokers subjects (p < 0.0001, p < 0.